These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 15148765)
1. Clinicopathological outcome of radical retropubic prostatectomy for 200 men with prostate cancer in a single institution in Japan. Miyake H; Sakal I; Harada K; Eto H; Hara I Hinyokika Kiyo; 2004 Mar; 50(3):151-6. PubMed ID: 15148765 [TBL] [Abstract][Full Text] [Related]
2. Long-term results of adjuvant hormonal therapy plus radiotherapy following radical prostatectomy for patients with pT3N0 or pT3N1 prostate cancer. Miyake H; Sakai I; Harada K; Hara I; Eto H Int J Urol; 2004 Jun; 11(6):397-401. PubMed ID: 15157209 [TBL] [Abstract][Full Text] [Related]
3. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy. Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480 [TBL] [Abstract][Full Text] [Related]
4. Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer. Zincke H; Lau W; Bergstralh E; Blute ML J Urol; 2001 Dec; 166(6):2208-15. PubMed ID: 11696737 [TBL] [Abstract][Full Text] [Related]
5. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. DiMarco DS; Zincke H; Sebo TJ; Slezak J; Bergstralh EJ; Blute ML J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719 [TBL] [Abstract][Full Text] [Related]
6. Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy. Schumacher MC; Burkhard FC; Thalmann GN; Fleischmann A; Studer UE Eur Urol; 2008 Aug; 54(2):344-52. PubMed ID: 18511183 [TBL] [Abstract][Full Text] [Related]
7. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776 [TBL] [Abstract][Full Text] [Related]
8. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. Boorjian SA; Thompson RH; Siddiqui S; Bagniewski S; Bergstralh EJ; Karnes RJ; Frank I; Blute ML J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342 [TBL] [Abstract][Full Text] [Related]
9. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. Roehl KA; Han M; Ramos CG; Antenor JA; Catalona WJ J Urol; 2004 Sep; 172(3):910-4. PubMed ID: 15310996 [TBL] [Abstract][Full Text] [Related]
10. Natural history of disease progression in patients who fail to achieve an undetectable prostate-specific antigen level after undergoing radical prostatectomy. Rogers CG; Khan MA; Craig Miller M; Veltri RW; Partin AW Cancer; 2004 Dec; 101(11):2549-56. PubMed ID: 15470681 [TBL] [Abstract][Full Text] [Related]
11. Surgical management of lymph-node-positive prostate cancer: improves symptomatic control. Wiegand LR; Hernandez M; Pisters LL; Spiess PE BJU Int; 2011 Apr; 107(8):1238-42. PubMed ID: 20880197 [TBL] [Abstract][Full Text] [Related]
12. Radical prostatectomy for clinical T4 prostate cancer. Johnstone PA; Ward KC; Goodman M; Assikis V; Petros JA Cancer; 2006 Jun; 106(12):2603-9. PubMed ID: 16700037 [TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy. Lee HM; Solan MJ; Lupinacci P; Gomella LG; Valicenti RK Urology; 2004 Jul; 64(1):84-9. PubMed ID: 15245941 [TBL] [Abstract][Full Text] [Related]
14. Role of postoperative radiotherapy after pelvic lymphadenectomy and radical retropubic prostatectomy: a single institute experience of 415 patients. Cozzarini C; Bolognesi A; Ceresoli GL; Fiorino C; Rossa A; Bertini R; Colombo R; Da Pozzo L; Montorsi F; Roscigno M; Calandrino R; Rigatti P; Villa E Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):674-83. PubMed ID: 15183470 [TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184 [TBL] [Abstract][Full Text] [Related]
16. Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study. Siddiqui SA; Boorjian SA; Inman B; Bagniewski S; Bergstralh EJ; Blute ML J Urol; 2008 May; 179(5):1830-7; discussion 1837. PubMed ID: 18353378 [TBL] [Abstract][Full Text] [Related]
18. Contemporary survival results and the role of radiation therapy in patients with node negative seminal vesicle invasion following radical prostatectomy. Eggener SE; Roehl KA; Smith ND; Antenor JA; Han M; Catalona WJ J Urol; 2005 Apr; 173(4):1150-5. PubMed ID: 15758725 [TBL] [Abstract][Full Text] [Related]